Skip to main content
SpringerLink
Log in

Consumption of soy products and cardiovascular mortality in people with and without cardiovascular disease: a prospective cohort study of 0.5 million individuals

European Journal of Nutrition volume 60, pages 4429–4438 (2021)Cite this article

Abstract

Purpose

We sought to examine the association of soy product consumption with risk of cardiovascular death in Chinese individuals with and without a history of cardiovascular disease (CVD).

Methods

The current analysis included 487,034 individuals free of CVD and 22,923 individuals with a history of CVD at study baseline. Data on consumption of soy products were collected by a food frequency questionnaire. The Cox regression was used to obtain the hazard ratios (HRs) of cardiovascular mortality associated with soy product consumption among people with and without a history of CVD at baseline.

Results

During the period of follow-up, 12,582 and 2860 cardiovascular deaths were recorded among people without and with a history of CVD. Compared with those who never or rarely ate soy products, the multivariable HRs (95% CIs) were 1.02 (0.96, 1.08) for those who ate soy products monthly, 1.01 (0.95, 1.07) for those who ate soy products 1–3 days per week, 0.95 (0.88, 1.04) for those who ate soy products ≥ 4 days per week. For cause-specific mortality, soy product consumption was inversely associated with mortality from acute myocardial infarction (HR [95% CI] = 0.75 [0.61, 0.92]). Among people with a history of CVD, higher soy product consumption was not associated with cardiovascular mortality.

Conclusions

Soy consumption ≥ 4 days per week was associated with a significantly lower risk of mortality from acute myocardial infarction in comparison with never or rarely consumption among people without a history of CVD. Among people with a history of CVD, higher soy product consumption was not associated with cardiovascular mortality.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

Abbreviations

AMI:

Acute myocardial infarction

CHD:

Coronary heart disease

CI:

Confidence interval

CKB:

China Kadoorie Biobank

CVD:

Cardiovascular disease

HR:

Hazard ratio

References

  1. Dong JY, Tong X, Wu ZW, Xun PC, He K, Qin LQ (2011) Effect of soya protein on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 106(3):317–326. https://doi.org/10.1017/s0007114511000262

    Article  PubMed  CAS  Google Scholar 

  2. Tokede OA, Onabanjo TA, Yansane A, Gaziano JM, Djoussé L (2015) Soya products and serum lipids: a meta-analysis of randomised controlled trials. Br J Nutr 114(6):831–843. https://doi.org/10.1017/s0007114515002603

    Article  PubMed  CAS  Google Scholar 

  3. Beavers DP, Beavers KM, Miller M, Stamey J, Messina MJ (2012) Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 22(3):182–191. https://doi.org/10.1016/j.numecd.2010.05.007

    Article  PubMed  CAS  Google Scholar 

  4. Man B, Cui C, Zhang X, Sugiyama D, Barinas-Mitchell E, Sekikawa A (2020) The effect of soy isoflavones on arterial stiffness: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. https://doi.org/10.1007/s00394-020-02300-6

    Article  PubMed  Google Scholar 

  5. Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S (2007) Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 116(22):2553–2562. https://doi.org/10.1161/circulationaha.106.683755

    Article  PubMed  CAS  Google Scholar 

  6. Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H, Jin F, Zheng W (2003) Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133(9):2874–2878. https://doi.org/10.1093/jn/133.9.2874

    Article  PubMed  CAS  Google Scholar 

  7. Nagata C, Wada K, Tamura T, Konishi K, Goto Y, Koda S, Kawachi T, Tsuji M, Nakamura K (2017) Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. Am J Clin Nutr 105(2):426–431. https://doi.org/10.3945/ajcn.116.137281

    Article  PubMed  CAS  Google Scholar 

  8. Talaei M, Koh WP, van Dam RM, Yuan JM, Pan A (2014) Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr 144(6):921–928. https://doi.org/10.3945/jn.114.190454

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Ma L, Liu G, Ding M, Zong G, Hu FB, Willett WC, Rimm EB, Manson JE, Sun Q (2020) Isoflavone Intake and the risk of coronary heart disease in US Men and Women: results From 3 Prospective Cohort Studies. Circulation 141(14):1127–1137. https://doi.org/10.1161/circulationaha.119.041306

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, Liu J, Zhang M, Qi J, Yu S, Afshin A, Gakidou E, Glenn S, Krish VS, Miller-Petrie MK, Mountjoy-Venning WC, Mullany EC, Redford SB, Liu H, Naghavi M, Hay SI, Wang L, Murray CJL, Liang X (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 394(10204):1145–1158. https://doi.org/10.1016/S0140-6736(19)30427-1

    Article  Google Scholar 

  11. Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, Avezum A, Probstfield JL, Dans T, Yusuf S (2012) Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation 126(23):2705–2712. https://doi.org/10.1161/circulationaha.112.103234

    Article  PubMed  CAS  Google Scholar 

  12. Iestra J, Knoops K, Kromhout D, de Groot L, Grobbee D, van Staveren W (2006) Lifestyle, Mediterranean diet and survival in European post-myocardial infarction patients. Eur J Cardiovasc Prevent Rehabil 13(6):894–900. https://doi.org/10.1097/01.hjr.0000201517.36214.ba

    Article  Google Scholar 

  13. Li S, Chiuve SE, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Mukamal KJ, Rimm EB (2013) Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med 173(19):1808–1818. https://doi.org/10.1001/jamainternmed.2013.9768

    Article  PubMed  Google Scholar 

  14. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, Fung TT, Li S, Willett WC, Rimm EB, Hu FB (2014) The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am J Clin Nutr 99(1):172–180. https://doi.org/10.3945/ajcn.113.068106

    Article  PubMed  CAS  Google Scholar 

  15. Sijtsma FP, Soedamah-Muthu SS, de Hoon SE, Jacobs DR Jr, Kromhout D (2015) Healthy eating and survival among elderly men with and without cardiovascular-metabolic diseases. Nutr Metab Cardiovasc Dis 25(12):1117–1124. https://doi.org/10.1016/j.numecd.2015.08.008

    Article  PubMed  CAS  Google Scholar 

  16. Suzuki T, Kohro T, Hayashi D, Yamazaki T, Nagai R (2012) Frequency and impact of lifestyle modification in patients with coronary artery disease: the Japanese Coronary Artery Disease (JCAD) study. Am Heart J 163(2):268–273. https://doi.org/10.1016/j.ahj.2011.10.014

    Article  PubMed  Google Scholar 

  17. Trichopoulou A, Bamia C, Norat T, Overvad K, Schmidt EB, Tjønneland A, Halkjaer J, Clavel-Chapelon F, Vercambre MN, Boutron-Ruault MC, Linseisen J, Rohrmann S, Boeing H, Weikert C, Benetou V, Psaltopoulou T, Orfanos P, Boffetta P, Masala G, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Ocke MC, Peeters PH, Van der Schouw YT, González C, Sanchez MJ, Chirlaque MD, Moreno C, Larrañaga N, Van Guelpen B, Jansson JH, Bingham S, Khaw KT, Spencer EA, Key T, Riboli E, Trichopoulos D (2007) Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study. Eur J Epidemiol 22(12):871–881. https://doi.org/10.1007/s10654-007-9190-6

    Article  PubMed  CAS  Google Scholar 

  18. Trichopoulou A, Bamia C, Trichopoulos D (2005) Mediterranean diet and survival among patients with coronary heart disease in Greece. Arch Intern Med 165(8):929–935. https://doi.org/10.1001/archinte.165.8.929

    Article  PubMed  Google Scholar 

  19. Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, Li L, Biobank CK, collaborative g, (2011) China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 40(6):1652–1666. https://doi.org/10.1093/ije/dyr120

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H, Yang L, Chen Y, Zhang X, Wang T, Chen J, Chen Z, Yu C, Huo D, Li L (2020) Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. Eur J Epidemiol 35(6):567–578. https://doi.org/10.1007/s10654-019-00585-4

    Article  PubMed  CAS  Google Scholar 

  21. Yang G, Hu J, Rao KQ, Ma J, Rao C, Lopez AD (2005) Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr 3(1):3. https://doi.org/10.1186/1478-7954-3-3

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kao TH, Chen BH (2006) Functional components in soybean cake and their effects on antioxidant activity. J Agric Food Chem 54(20):7544–7555. https://doi.org/10.1021/jf061586x

    Article  PubMed  CAS  Google Scholar 

  23. Kao TH, Wu WM, Hung CF, Wu WB, Chen BH (2007) Anti-inflammatory effects of isoflavone powder produced from soybean cake. J Agric Food Chem 55(26):11068–11079. https://doi.org/10.1021/jf071851u

    Article  PubMed  CAS  Google Scholar 

  24. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. The Journal of nutrition 133 (5):1238–1243. doi:https://doi.org/10.1093/jn/133.5.1238

  25. Taku K, Lin N, Cai D, Hu J, Zhao X, Zhang Y, Wang P, Melby MK, Hooper L, Kurzer MS, Mizuno S, Ishimi Y, Watanabe S (2010) Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials. J Hypertens 28(10):1971–1982. https://doi.org/10.1097/HJH.0b013e32833c6edb

    Article  PubMed  CAS  Google Scholar 

  26. Moradi M, Daneshzad E, Azadbakht L (2019) The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. doi:https://doi.org/10.1080/10408398.2019.1689097

  27. Katagiri R, Sawada N, Goto A, Yamaji T, Iwasaki M, Noda M, Iso H, Tsugane S (2020) Association of soy and fermented soy product intake with total and cause specific mortality: prospective cohort study. BMJ (Clin Res ed) 368:m34. https://doi.org/10.1136/bmj.m34

    Article  Google Scholar 

  28. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302(18):1993–2000. https://doi.org/10.1001/jama.2009.1619

    Article  PubMed  Google Scholar 

  29. Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41(24):2313–2330. https://doi.org/10.1093/eurheartj/ehz962

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Gofman JW, Lindgren F (1950) The role of lipids and lipoproteins in atherosclerosis. Science 111(2877):166–171. https://doi.org/10.1126/science.111.2877.166

    Article  PubMed  CAS  Google Scholar 

  31. Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81(2):397–408. https://doi.org/10.1093/ajcn.81.2.397

    Article  PubMed  CAS  Google Scholar 

  32. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85(4):1148–1156. https://doi.org/10.1093/ajcn/85.4.1148

    Article  PubMed  CAS  Google Scholar 

  33. Blanco Mejia S, Messina M, Li SS, Viguiliouk E, Chiavaroli L, Khan TA, Srichaikul K, Mirrahimi A, Sievenpiper JL, Kris-Etherton P, Jenkins DJA (2019) A meta-analysis of 46 studies identified by the fda demonstrates that soy protein decreases circulating LDL and total cholesterol concentrations in adults. J Nutr 149(6):968–981. https://doi.org/10.1093/jn/nxz020

    Article  PubMed  PubMed Central  Google Scholar 

  34. Tang Y, Li S, Zhang P, Zhu J, Meng G, Xie L, Yu Y, Ji Y, Han Y (2016) Soy isoflavone protects myocardial ischemia/reperfusion injury through increasing endothelial nitric oxide synthase and decreasing oxidative stress in ovariectomized rats. Oxid Med Cell Longev 2016:5057405. https://doi.org/10.1155/2016/5057405

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Tang WHW, Bäckhed F, Landmesser U, Hazen SL (2019) Intestinal microbiota in cardiovascular health and disease: jacc state-of-the-art review. J Am Coll Cardiol 73(16):2089–2105. https://doi.org/10.1016/j.jacc.2019.03.024

    Article  PubMed  PubMed Central  Google Scholar 

  36. Atkinson C, Frankenfeld CL, Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230(3):155–170. https://doi.org/10.1177/153537020523000302

    Article  CAS  Google Scholar 

  37. Lokuruka M (2011) Effects of processing on soybean nutrients and potential impact on consumer health: an overview. African Journal of Food, Agriculture, Nutrition and Development 11 (4)

  38. Gencel VB, Benjamin MM, Bahou SN, Khalil RA (2012) Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini Rev Med Chem 12(2):149–174. https://doi.org/10.2174/138955712798995020

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Zhao JV, Kwok MK, Schooling CM (2019) Effect of glutamate and aspartate on ischemic heart disease, blood pressure, and diabetes: a Mendelian randomization study. Am J Clin Nutr 109(4):1197–1206. https://doi.org/10.1093/ajcn/nqy362

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Data were obtained from CKB Data Access System (www.ckbiobank.org, DAR-2019-00016). We thank all the participants in the study, the members of the survey teams in the ten regional centers of China, as well as to the project development and management teams based at Beijing, Oxford, and the ten regional centers. The members of the China Kadoorie Biobank are as follows: International Steering Committee: Junshi Chen, Zhengming Chen (principal investigator), Rory Collins, Liming Li (principal investigator), Richard Peto. Inter- national Co-ordinating Centre, Oxford: Daniel Avery, Derrick Bennett, Yumei Chang, Yip- ing Chen, Zhengming Chen, Robert Clarke, Huaidong Du, Xuejuan Fan, Haiyan Gao, Simon Gilbert, Michael Holmes, Andri Iona, Rene Kerosi, Ling Kong, Om Kurmi, Garry Lancaster, Sarah Lewington, John McDonnell, Winnie Mei, Iona Millwood, Qunhua Nie, Jayakrishnan Radhakrishnan, Paul Ryder, Sam Sansome, Dan Schmidt, Paul Sherliker, Rajani Sohoni, Robin Walters, Jenny Wang, Lin Wang, Alex Williams, Ling Yang, Xiaoming Yang. National Co-ordinating Centre, Beijing: Zheng Bian, Ge Chen, Lei Guo, Yu Guo, Bingyang Han, Can Hou, Peng Liu, Jun Lv, Pei Pei, Shuzhen Qu, Yunlong Tan, Canqing Yu, Huiyan Zhou. Regional Co-ordinating Centres (in bold) and local Centers for Disease Control and Pre- vention (CDCs): Qingdao CDC: Zengchang Pang, Shutao Pang, Shaojie Wang, Yongmei Liu, Ranran Du, Yajing Zang, Liang Cheng. Licang CDC: Silu Lv, Junzheng Wang, Wei Hou. Hei- longjiang CDC: Jiyuan Yin, Shumei Liu, Zhigang Pang, Xue Zhou, Huijun Wang. Nangang CDC: Liqiu Yang, Bo Yu, Yanjie Li, Jing Qi, Huaiyi Mu, Qin’ai Xu, Meiling Dou. Hainan CDC: Jianwei Du, Shanqing Wang, Ximin Hu, Hongmei Wang, Jinyan Chen, Yan Fu, Zhenwang Fu, Xiaohuan Wang, Hua Dong. Meilan CDC: Min Weng, Xiangyang Zheng, Yijun Li, Huimei Li. Jiangsu CDC: Ming Wu, Jinyi Zhou, Ran Tao, Jie Yang. Suzhou CDC: Jie Shen, Yihe Hu, Yan Lu, Yan Gao, Liangcai Ma, Aiyu Tang, Shuo Zhang, Jianrong Jin. Guangxi CDC: Zhenzhu Tang, Naying Chen, Ying Huang. Liuzhou CDC: Mingqiang Li, Jinhuai Meng, Rong Pan, Qilian Jiang, Jingxin Qin, Weiyuan Zhang, Yun Liu, Liuping Wei, Liyuan Zhou, Ningyu Chen, Jun Yang, Hairong Guan. Sichuan CDC: Xianping Wu, Ningmei Zhang, Xiao- fang Chen, Xuefeng Tang. Pengzhou CDC: Guojin Luo, Jianguo Li, Xiaofang Chen, Jian Wang, Jiaqiu Liu, Qiang Sun. Gansu CDC: Pengfei Ge, Xiaolan Ren, Caixia Dong. Maiji CDC: Hui Zhang, Enke Mao, Xiaoping Wang, Tao Wang. Henan CDC: Guohua Liu, Baoyu Zhu, Gang Zhou, Shixian Feng, Liang Chang, Lei Fan. Huixian CDC: Yulian Gao, Tianyou He, Li Jiang, Huarong Sun, Pan He, Chen Hu, Qiannan Lv, Xukui Zhang. Zhejiang CDC: Min Yu, Ruying Hu, Le Fang, Hao Wang. Tongxiang CDC: Yijian Qian, Chunmei Wang, Kaixue Xie, Lingli Chen, Yaxing Pan, Dongxia Pan. Hunan CDC: Yuelong Huang, Biyun Chen, Donghui Jin, Huilin Liu, Zhongxi Fu, Qiaohua Xu. Liuyang CDC: Xin Xu, Youping Xiong, Weifang Jia, Xianzhi Li, Libo Zhang, Zhe Qiu.

Funding

The Chinese Kadoorie Biobank study has received funding from the British Heart Foundation, Cancer Research UK, Chinese Ministry of Science and Technology, Chinese National Natural Science Foundation, the Kadoorie Charitable Foundation in Hong Kong, Medical Research Council UK and the Wellcome Trust. This work was funded by the Fuji Foundation for Protein Research to J.-Y. D.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100191, China

    Xiaowen Wang, Canqing Yu, Jun Lv, Liming Li & Yonghua Hu

  2. Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Osaka, 5650871, Japan

    Xiaowen Wang, Keyang Liu, Kokoro Shirai, Hiroyasu Iso & Jia-Yi Dong

Authors
  1. Xiaowen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Canqing Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liming Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yonghua Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keyang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kokoro Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroyasu Iso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jia-Yi Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

X.W. and J-Y. D. designed the study, analyzed the data, and wrote the manuscript. All authors conducted the technique review and reviewed and edited the manuscript. J-Y. D. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding author

Correspondence to Jia-Yi Dong.

Ethics declarations

Competing interests

None declared.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 26 kb)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Yu, C., Lv, J. et al. Consumption of soy products and cardiovascular mortality in people with and without cardiovascular disease: a prospective cohort study of 0.5 million individuals. Eur J Nutr 60, 4429–4438 (2021). https://doi.org/10.1007/s00394-021-02602-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-021-02602-3

Keywords

search

Navigation